Younger blood startup is again, a scoop about CityMD, and telling remarks from Merck's CEO

Share with your Friends
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Doctor and patient. Office visit. Ivan Mendoza, MD, associate medical director for the Jackson Medical Group's cardiology practice, (L) shows where the worlds smallest pacemaker is located in Felipe Finale, 78, during a media event at Jackson South Community Hospital to announce his successful implant of the pacemaker into Felipe, a first for a South Florida hospital on September 8, 2016 in Miami, Florida.Hi there,

Welcome to this week’s version of Disbursed, our weekly healthcare publication right here at Enterprise Insider, the place we’re hoping for sunnier climate after this wet week. Lydia Ramsey is letting me (healthcare editor Zachary Tracer) take over this week whereas she’s off on trip.

Questions? Complaints? E-mail me at ztracer@businessinsider.com.

New to our publication? You can join Disbursed right here.

First, the scoops: 

  • Warburg Pincus is shopping for considered one of New Jersey’s greatest physician teams, and mixing it with ubiquitous NYC-area urgent-care chain CityMD. Learn Lydia’s full story right here.
  • Emma Courtroom tracked down the pitch deck that healthcare AI startup Cardinal Analytx used to lift its Collection B. Click on right here to see the deck and skim Emma’s evaluation.
  • Keep in mind Ambrosia? That is the startup that, for $eight,000, promised to offer you an infusion of blood from younger individuals. Erin Brodwin stories that it is again up and working, after pausing operations when the FDA warned in opposition to the process.

Erin additionally revealed one other story on the troubled poop-testing startup uBiome. This story focuses on the corporate’s short-lived partnership with Nurx, a startup that sells contraception on-line and lately bumped into issues of its personal.

Table of Contents

Embattled $600 million poop-testing startup uBiome as soon as partnered with Nurx, a contraception firm on the heart of a New York Instances exposé

  • The Silicon Valley well being startup uBiome is in sizzling water on the heels of an FBI raid in April.
  • Based in 2012, uBiome raised $105 million from traders on the promise of exploring the microbiome, a “forgotten organ.”
  • As uBiome superior from a citizen science venture to a clinical-testing firm, it overstated the medical worth of its assessments and prioritized progress over affected person care, as reported by Enterprise Insider earlier this month.
  • For a time, uBiome additionally used docs who belonged to the scientific care community of Nurx, a contraception startup that was later on the heart of a New York Instances exposé, insiders instructed Enterprise Insider.
  • Points between Nurx and uBiome arose when Nurx required uBiome sufferers to submit photograph IDs, insiders stated. Additionally, Nurx physicians weren’t approving uBiome’s assessments rapidly sufficient, based on the insiders.

Want a refresher on all of our uBiome protection? You could find it right here.

To begin the week, Collective Well being raised $205 million in a funding spherical led by SoftBank Imaginative and prescient Fund. Firms like Uber and Palantir use Collective Well being to handle their staff’ well being advantages. You may learn the complete story right here.

In the meantime, Emma and Clarrie Feinstein dug into Pfizer’s $11 billion deal for the most cancers biotech Array BioPharma. Click on right here to learn Emma’s evaluation of what the acquisition means for Pfizer’s technique to struggle most cancers. And here is what the deal means for traders.

TOP NEWS  make a dangling indent in Google Docs, for works cited pages and extra

Cancer-loaded DNA adheres to stable substances, such as gold.

three biotechs that traders should purchase subsequent after Pfizer’s $11 billion deal for most cancers drugmaker Array BioPharma

Emma additionally dug right into a revealing lawsuit involving CVS Well being and Amazon’s PillPack enterprise. The takeaway: healthcare giants like UnitedHealth Group and CVS may face elevated competitors.

We simply received the primary take a look at how Amazon’s $750 million acquisition of PillPack may upend the US healthcare system

  • Amazon acquired the web pharmacy PillPack a yr in the past, signaling an entry by the highly effective on-line retail big into healthcare.
  • We simply received a peek at Amazon’s disruptive new method by way of a current lawsuit, which alleges that PillPack is competing with large firms like CVS and UnitedHealth for a billion-dollar enterprise.
  • Although it is onerous to know what’s going to occur, the event might be adverse for CVS, UnitedHealth, and different healthcare firms, the Jefferies analyst Brian Tanquilut and his staff stated.

Uptown, the drugmaker Merck held its first investor day in half a decade. Two questions have been high of thoughts for traders: Who’s going to succeed Merck CEO Ken Frazier? And what’s subsequent for Merck after the blockbuster most cancers remedy Keytruda?

One essential quote from Merck CEO Ken Frazier at an occasion for big-time traders in Manhattan reveals the US drug big at a crossroads

  • US drug big Merck hosted a swanky occasion on Manhattan’s Higher East Facet for traders on Thursday the place it mapped out the way forward for the corporate.
  • Most cancers drug Keytruda has turn out to be Merck’s high product and can proceed to develop, Merck executives stated. However “we do have super progress alternatives past Keytruda,” CEO Kenneth Frazier instructed the viewers.
  • The corporate can be getting ready for management change on the high, after almost a decade being led by Frazier.
TOP NEWS  I used to be one of many first overtly trans staff in tech. This is what has modified since I got here out within the '90s — and what has stayed the identical

Lastly, I am going to go away you with some sensible interviews from the healthcare staff this week.

  • Sheila Gujrathi, the CEO of Gossamer Bio, gave us her finest recommendation for docs who resolve they do not wish to apply drugs. We additionally talked to her about the right way to put together to be a first-time CEO.
  • Justin Gover, the CEO of GW Pharma, instructed us what’s subsequent for cannabis-based pharmaceuticals. GW Pharma launched the primary such drug, an epilepsy remedy referred to as Epidiolex, final summer time.
  • UnityPoint Well being simply began a brand new $100 million enterprise fund. Managing Director Matthew Warrens gave us an inside take a look at the technique.
  • B.J. Moore, the brand new chief info officer at Windfall St. Joseph Well being, instructed us in regards to the alternatives and tech challenges at a well being system with 51 hospitals and 14 completely different digital health-records techniques.

On a private notice, right now’s my final day in New York. I am going to nonetheless be working right here at BI, simply from a brand new perch in Philadelphia. Need to meet up in Philly? Have a favourite spot for vegetarian cheesesteaks? I am at ztracer@businessinsider.com.

It’s also possible to attain the entire staff at healthcare@businessinsider.com.

-Zach

Be part of the dialog about this story »

NOW WATCH: Your pillowcase has extra micro organism than your rest room seat if you happen to do not wash your sheets typically


Share with your Friends
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •